Results 81 to 90 of about 449,138 (190)

Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36 [PDF]

, 2001
Kufor-Rakeb syndrome is an autosomal recessive nigro-striatal-pallidal-pyramidal neurodegeneration. The onset is in the teenage years with clinical features of Parkinson’s disease plus spasticity, supranuclear upgaze paresis, and dementia.
Al-Din, A., Bond, J., Crow, Y., Hampshire, D.J., Mubaidin, A., Roberts, E., Woods, C.G., Wriekat, A.L.   +7 more
core   +2 more sources

Online cognitive monitoring technology for people with Parkinson’s disease and REM sleep behavioural disorder

npj Digital Medicine
Automated online cognitive assessments are set to revolutionise clinical research and healthcare. However, their applicability for Parkinson’s Disease (PD) and REM Sleep Behavioural Disorder (RBD), a strong PD precursor, is underexplored.
Maria Bălăeţ, Falah Alhajraf, Tanja Zerenner, Jessica Welch, Jamil Razzaque, Christine Lo, Valentina Giunchiglia, William Trender, Annalaura Lerede, Peter J. Hellyer, Sanjay G. Manohar, Paresh Malhotra, Michele Hu, Adam Hampshire   +13 more
doaj   +1 more source

Additional file 2: of Blood transcriptomics of drug-naĂŻve sporadic Parkinsonâ s disease patients

, 2015
Score plots of the first 6 PCs calculated on the dataset constituted by the 395 variables selected by Ranking-PCA. Control samples are represented as filled circles while pathological samples as void circles. Of the original 60 samples, one (a control sample) did not pass the microarray hybridization quality controls and was excluded from further ...
Calligaris, Raffaella, Banica, Mihaela, Roncaglia, Paola, Robotti, Elisa, Finaurini, Sara, Vlachouli, Christina, Antonutti, Lucia, Iorio, Francesco, Carissimo, Annamaria, Cattaruzza, Tatiana, Ceiner, Andrea, Lazarevic, Dejan, Cucca, Alberto, Pangher, Nicola, Marengo, Emilio, Bernardo, Diego Di, Pizzolato, Gilberto, Gustincich, Stefano   +17 more
openaire   +1 more source

Using 'dead or dependent' as an outcome measure in clinical trials in Parkinson's disease [PDF]

, 2014
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.Peer reviewedPublisher ...
Counsell, Carl, Fielding, Shona, McGhee, David, Parker, Alexander, Zajicek, John   +4 more
core   +1 more source

Additional file 2: of Meta-analysis of risk factors for Parkinsonâ s disease dementia

, 2016
Details of the study results. This file provided detailed results of meta-analysis of each risk factor. (DOCX 159 kb)
Yaqian Xu, Yang, Jing, Huifang Shang
openaire   +1 more source

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

Translational Neurodegeneration, 2020
Background The efficacy and safety of opicapone, a once-daily catechol-O-methyltransferase inhibitor, have been established in two large randomized, placebo-controlled, multinational pivotal trials.
Heinz Reichmann, Andrew Lees, José-Francisco Rocha, Diogo Magalhães, Patrício Soares-da-Silva, the OPTIPARK investigators   +5 more
doaj   +1 more source

Dental amalgam fillings: An under-investigated source of mercury exposure [PDF]

, 2019
Dental amalgam fillings, which contain about 50% mercury, have been used since the early 19th century. However, their use has been controversial, particularly because they continually release small amounts of mercury.
Ahlqwist, Ahlqwist, Ahlqwist, Bailer, Bangsi, Barregard, Barregard, Barregard, Bates, Bellinger, Bellinger, Bellinger, Bjorkman, Bjørklund, Boyd, Bratel, Bratel, Casetta, Clarkson, Clarkson, Counter, Daniels, de Burbure, DeRouen, Dye, Eti, Factor-Litvak, Ganss, Goldwater, Gun, Herrstrom, Herrstrom, Herrstrom, Herrstrom, Hsu, Hujoel, Hyson, Kingman, Lund, Malt, McGrother, Melchart, Nylander, Rothwell, Sandborgh-Englund, Saxe, Saxe, Schuurs, Seidler, Siblerud, Siblerud, Siblerud, Soler, Sun, Woods, World Health Organization   +55 more
core   +1 more source

Additional file 1: of Meta-analysis of risk factors for Parkinsonâ s disease dementia

, 2016
Details of studies included in the meta-analysis. This file included details of all studies included in this meta-analysis, categorized by risk factors. Details including first author, year of publication, country, study design, number of participants and NOS scores. (DOCX 119 kb)
Yaqian Xu, Yang, Jing, Huifang Shang
openaire   +1 more source

Functional magnetic stimulation in constipation associated with Parkinson’s disease

Journal of Rehabilitation Medicine, 2009
The aims of this study were: (i) to investigate the effect of functional magnetic stimulation on total colonic transit time in patients with Parkinson's disease; (ii) to compare the changes in dynamic recto-anal behaviour during filling and defaecation in response to this regimen; and (iii) to study the carry-over effects with a 3-month follow-up.A ...
Cheng-Ming, Chiu, Chih-Pin, Wang, Wen-Hsu, Sung, Shih-Fong, Huang, Shu-Chiung, Chiang, Po-Yi, Tsai   +5 more
openaire   +3 more sources

Management of rapid eye movement sleep behavior disorder in patients with Parkinson's disease [PDF]

, 2016
Among all of the devastating effects that Parkinson’s disease (PD) has on an individual, sleep dysfunction is one that can have a profound effect on the entire family of the patient. The most potentially destructive of these sleep syndromes being that of
Jeffries, Michael
core   +1 more source